[Prophylaxis of pulmonary embolism in pregnancy and puerperium].
Pulmonary embolism is the main cause of death of pregnant women in developed countries. An increased prothrombotic activity is observed during pregnancy. Moreover, the risk of venous thromboembolic disease can be elevated in cases of inherited thrombophilia, antiphospholipid syndrome or previous venous thromboembolic events. According to presented guidelines of The Royal College of Obstetricians and Gynecologists and The American College of Chest Physicians, the risk stratification of venous thromboembolic disease during pregnancy and puerperium is a vital condition and proper antithrombotic prophylaxis should be implemented.
Klinika Chorób Wewnetrznych i Kardiologii, Warszawski Uniwersytet Medyczny. maciej.kostrubiec@wum.edu.pl
Maciej
M
Kostrubiec
Nikola
N
Niewegłowska
Piotr
P
Pruszczyk
D019317:Evidence-Based Medicine; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000517:prevention & control*; D011644:Puerperal Disorders / Q000175:diagnosis / Q000517:prevention & control*; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000517:prevention & control*; D018570:Risk Assessment; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin
Profilaktyka zatorowości płucnej w ciazy i połogu.